as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹261.01
Change
+0.94 (0.36%)
Open
₹264.09
Prev. Close
₹260.07
Day High
₹264.09
Day Low
₹258.86
Volume Analysis
Traded
2,053
Delivered
856
Delivery %
41.7%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹269.01 | ₹266.55 | ₹263.78 | ₹261.32 | ₹258.55 | ₹256.09 | ₹253.32 |
| Fibonacci | ₹266.55 | ₹264.55 | ₹263.32 | ₹261.32 | ₹259.32 | ₹258.09 | ₹256.09 |
| Camarilla | ₹262.45 | ₹261.97 | ₹261.49 | ₹261.32 | ₹260.53 | ₹260.05 | ₹259.57 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+0.97%
1 Week
-0.86%
1 Month
+0.57%
3 Months
-1.95%
6 Months
+1.18%
1 Year
+0.68%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Icici10gs lands in the middle of the pack on TopFund's composite fundamentals check, at 50/100. The strongest factor is Risk & Volatility (75/100), while Liquidity (21/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Icici10gs?
Frequently Asked Questions about Icicipramc - Icici10gs
Icicipramc - Icici10gs (GSEC10IETF) closed at ₹261.01 on NSE on 19 November 2026, up 0.94 (0.36%) from the previous close.
Icicipramc - Icici10gs trades on the NSE (National Stock Exchange of India) under the symbol GSEC10IETF.
Icicipramc - Icici10gs has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Icici10gs?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.